Introduction/Aim. Understanding the mechanisms and classification of drug interactions can significantly reduce the occurrence of adverse effects and improve compliance. The drug selection process is complex and involves the patient's individual condition, physiological status, use of other drugs, and co-existing illnesses. It is particularly chall...

By Sanja Stanković, Nikola Stefanović, Maša Jović, Radmila Veličković-Radovanović

Introduction/Aim. Polypharmacy can increase the risk of side effects and cause adverse drug interactions with a significant impact on the course of the basic disease. The aim of the study was to determine the frequency of polypharmacy and examine its impact on the risk of drug-drug interactions in patients with rheumatoid arthritis (RA). The resear...

By Nikola Krstić, Nikola Stefanović, Milan Petronijević, Ivana Damnjanović

Introduction. Standard biomarkers for the diagnosis and follow-up of chronic kidney disease patients are appropriate neither in early diagnostics, adequate follow-up and progression assessment nor in complication development risk assessment. For that reason, a search for new, more suitable biomarkers continues. Various studies suggested microRNAs a...

By Vladana Stojiljković, Nikola Stefanović, Marija Vukelić-Nikolić, Branka Đorđević, Jelena Bašić, Gordana Kocić, Tatjana Cvetković

Summary The presence of diabetes mellitus leads to a decrease in life quality in all domains. The aim of our study was to evaluate the quality of life (QOL) in diabetic patients and the factors affecting it in type 2 diabetic mellitus patients. We conducted a cross-sectional study that included 86 patients with type 2 diabetes mellitus, i...

By Ana Spasić, Radmila Veličković Radovanović, Aleksandra Catić Đorđević, Nikola Stefanović, Tatjana Cvetković